the company is making progress; perhaps not as fast as some would like, but this is a company selling for about 1X sales. Most companies that show growth with these kind of GMs should be selling at close to 4X; so if you bleive that they can grow revs at 20% per year, and then get a 4 times multiple on that, you have a $10 stock in a few years
This made of laugh and laugh ever in my life
In other thing that I would like to ask is that BIOLASE in our opinion has been really misplaced in the category of capital equipment, while we’re not ready to capital equipment per se company, yes we sell equipment but we have intellectual properties the huge amount of intellectual properties that what we have done a BIOLASE is that we invented that and perfected a new surgical device to look at human and animal tissue. With a minimal examine -- in the most biological way so we are the best surgical system today biologically compared to any other surgical system out there.
So I frankly believe that BIOLASE should be as a biomedical company not as a medical technology company. We don’t sell dental chairs, pacemakers, dental burs or just noble equipment. We have invented the technology that back to the other molecular level. And but we also manufacture the product, so really it is I get upset when I see BIOLASE is being compared to company that in reality fewer catheter equipment companies, in the space of dentistry, we are much more than that and I hope that you investors going to start to looking at BIOLASE a different way.